Squamous cell carcinoma of the skin risk factors
|
Squamous cell carcinoma of the skin Microchapters |
|
Differentiating Squamous cell carcinoma of the skin from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Squamous cell carcinoma of the skin risk factors On the Web |
|
American Roentgen Ray Society Images of Squamous cell carcinoma of the skin risk factors |
|
Squamous cell carcinoma of the skin risk factors in the news |
|
Directions to Hospitals Treating Squamous cell carcinoma of the skin |
|
Risk calculators and risk factors for Squamous cell carcinoma of the skin risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
The risk factors for the Squamous cell carcinoma (SCC) include prolonged sunlight exposure, UV radiation, smoking, drugs etc.
Risk Factors
Common Risk Factors
Common risk factors for the development of the disease inlcude:[1]
- UV light exposure[2]
- UV light damages DNA, initiating a series of changes can result in malignant transformation
- Having skin that burns easily and does not tan or tans poorly
- Light-colored hair
- Older age
- Smoking
Less Common Risk factors
- Northern European ancestry
- Exposure to PUVA phototherapy
- Immunosuppressive treatment[3]
- Exposure to ionizing radiation and other industrial carcinogens[4]
- Chronic inflammation[5]
- Rare inherited disorders
- Arsenic exposure
- Genetic alterations[9]
- Family history[10]
- Drugs
- BRAF inhibitors
- Voriconazole[11]
- Other photosensitizing drugs like ibuprofen and isotretinoin[12]
References
- ↑ de Vries E, Trakatelli M, Kalabalikis D, Ferrandiz L, Ruiz-de-Casas A, Moreno-Ramirez D; et al. (2012). "Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study". Br J Dermatol. 167 Suppl 2: 1–13. doi:10.1111/j.1365-2133.2012.11081.x. PMID 22881582.
- ↑ de Gruijl FR, van Kranen HJ, Mullenders LH (2001). "UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer". J Photochem Photobiol B. 63 (1–3): 19–27. PMID 11684448.
- ↑ Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O; et al. (1999). "Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens". J Am Acad Dermatol. 40 (2 Pt 1): 177–86. PMID 10025742.
- ↑ Yoshinaga S, Hauptmann M, Sigurdson AJ, Doody MM, Freedman DM, Alexander BH; et al. (2005). "Nonmelanoma skin cancer in relation to ionizing radiation exposure among U.S. radiologic technologists". Int J Cancer. 115 (5): 828–34. doi:10.1002/ijc.20939. PMID 15704092.
- ↑ Jellouli-Elloumi A, Kochbati L, Dhraief S, Ben Romdhane K, Maalej M (2003). "[Cancers arising from burn scars: 62 cases]". Ann Dermatol Venereol. 130 (4): 413–6. PMID 12843850.
- ↑ Cleaver JE, Thompson LH, Richardson AS, States JC (1999). "A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy". Hum Mutat. 14 (1): 9–22. doi:10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.0.CO;2-6. PMID 10447254.
- ↑ Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C (2009). "Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006". J Am Acad Dermatol. 60 (2): 203–11. doi:10.1016/j.jaad.2008.09.035. PMID 19026465.
- ↑ Kromberg JG, Castle D, Zwane EM, Jenkins T (1989). "Albinism and skin cancer in Southern Africa". Clin Genet. 36 (1): 43–52. PMID 2766562.
- ↑ Tsai KY, Tsao H (2004). "The genetics of skin cancer". Am J Med Genet C Semin Med Genet. 131C (1): 82–92. doi:10.1002/ajmg.c.30037. PMID 15468170.
- ↑ Kharazmi E, Fallah M, Sundquist K, Hemminki K (2012). "Familial risk of early and late onset cancer: nationwide prospective cohort study". BMJ. 345: e8076. doi:10.1136/bmj.e8076. PMC 3527651. PMID 23257063.
- ↑ Cowen EW, Nguyen JC, Miller DD, McShane D, Arron ST, Prose NS; et al. (2010). "Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole". J Am Acad Dermatol. 62 (1): 31–7. doi:10.1016/j.jaad.2009.09.033. PMC 2815347. PMID 19896749.
- ↑ Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR (2013). "Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study". J Invest Dermatol. 133 (8): 1950–5. doi:10.1038/jid.2013.33. PMC 3655101. PMID 23344461.